3FMA Stock Overview Provides aesthetic medical services in the People’s Republic of China and Singapore. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteAesthetic Medical International Holdings Group Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Aesthetic Medical International Holdings Group Historical stock prices Current Share Price US$0.30 52 Week High US$0.52 52 Week Low US$0.10 Beta -0.12 1 Month Change 23.97% 3 Month Change 40.19% 1 Year Change -28.23% 3 Year Change -87.50% 5 Year Change n/a Change since IPO -93.18%
Recent News & Updates
First half 2024 earnings released: CN¥0.45 loss per share (vs CN¥0.24 loss in 1H 2023) Aug 21
New major risk - Market cap size Jul 25 Aesthetic Medical International Holdings Group Limited(OTCPK:PAIY.Y) dropped from NASDAQ Composite Index May 22
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel May 21
Aesthetic Medical International Holdings Group Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing Apr 27
Full year 2023 earnings released: CN¥0.84 loss per share (vs CN¥2.79 loss in FY 2022) Apr 26 See more updates
First half 2024 earnings released: CN¥0.45 loss per share (vs CN¥0.24 loss in 1H 2023) Aug 21
New major risk - Market cap size Jul 25 Aesthetic Medical International Holdings Group Limited(OTCPK:PAIY.Y) dropped from NASDAQ Composite Index May 22
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel May 21
Aesthetic Medical International Holdings Group Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing Apr 27
Full year 2023 earnings released: CN¥0.84 loss per share (vs CN¥2.79 loss in FY 2022) Apr 26
Aesthetic Medical International Holdings Group Limited to Report Fiscal Year 2023 Final Results on Apr 25, 2024 Apr 20
New minor risk - Financial data availability Mar 23
Aesthetic Medical International Holdings Announces Receipt of Letter of Expected Delisting Determination from Nasdaq Staff and Intention to Request Hearing Before the Nasdaq Hearings Panel Mar 09
Aesthetic Medical International Holdings Group Limited Announces Change of Director Dec 13
Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Sep 10
Second quarter 2023 earnings released: CN¥0.24 loss per share (vs CN¥0.062 loss in 2Q 2022) Sep 06 Aesthetic Medical International Holdings Group Limited Announces Board and Committee Changes
An unknown buyer entered into an agreement to acquire Shenzhen Miaoyan Medical Technology Investment Co., Ltd. from Aesthetic Medical International Holdings Group Limited (NasdaqCM:AIH) for CNY 1.9 million. May 18
Aesthetic Medical International Holdings Group Limited to Report Q1, 2023 Results on May 17, 2023 May 12
Full year 2022 earnings released: CN¥2.79 loss per share (vs CN¥26.68 loss in FY 2021) Apr 24 Aesthetic Medical International Holdings Group Limited announced that it has received CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) Feb 17
Aesthetic Medical International Holdings Receives a Letter of Expected Delisting Determination from Nasdaq Staff and Requests a Hearing Before the Nasdaq Hearings Panel Dec 07
Third quarter 2022 earnings released: CN¥1.12 loss per share (vs CN¥7.50 loss in 3Q 2021) Nov 30
Aesthetic Medical International Holdings Group Limited to Report Q3, 2022 Results on Nov 29, 2022 Nov 23
Less than half of directors are independent Nov 16
Second quarter 2022 earnings released: CN¥0.062 loss per share (vs CN¥1.65 loss in 2Q 2021) Aug 18
Aesthetic Medical International Holdings Group Limited to Report First Half, 2022 Results on Aug 17, 2022 Aug 11
Aesthetic Medical International Holdings Group Limited, Annual General Meeting, Sep 08, 2022 Aug 03
Less than half of directors are independent Jul 29 Aesthetic Medical International Holdings Group Limited announced that it expects to receive CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership Jul 21
Aesthetic Medical International Holdings Group Limited announced that it has received CNY 99.999999 million in funding from Lafang China Co.,Ltd, Hawyu (HK) Limited Jul 15
Aesthetic Medical International Receives Nasdaq Notice Regarding Non-Compliance with Minimum Stockholders’ Equity Requirement Jun 07
Less than half of directors are independent Apr 29
Aesthetic Medical International Announces Change of Board Members and Committee Composition Feb 19
Less than half of directors are independent Dec 17
Second quarter 2021 earnings released: CN¥1.65 loss per share (vs CN¥2.85 loss in 2Q 2020) Nov 18
Less than half of directors are independent Jul 27
First quarter 2021 earnings released: CN¥0.84 loss per share (vs CN¥3.66 loss in 1Q 2020) Jun 26
Aesthetic Medical International Holdings Group Limited Provides Revenue Guidance for the Second Quarter of 2021 Jun 25
Aesthetic Medical International Holdings Group Limited announced that it expects to receive $15.099993 million in funding from Lafang China Co.,Ltd May 18
Full year 2020 earnings released: EPS CN¥10.83 (vs CN¥8.87 in FY 2019) Apr 24
Aesthetic Medical International Holdings Group Limited Reports Impairment of Non-Current Assets for the Fourth Quarter of 2020 Apr 21 Shareholder Returns 3FMA DE Healthcare DE Market 7D 27.1% 1.1% 2.1% 1Y -28.2% 33.3% 16.5%
See full shareholder returns
Return vs Market: 3FMA underperformed the German Market which returned 16.7% over the past year.
Price Volatility Is 3FMA's price volatile compared to industry and market? 3FMA volatility 3FMA Average Weekly Movement 20.9% Healthcare Industry Average Movement 4.5% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: 3FMA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 3FMA's weekly volatility has decreased from 48% to 21% over the past year, but is still higher than 75% of German stocks.
About the Company Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People’s Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services.
Show more Aesthetic Medical International Holdings Group Limited Fundamentals Summary How do Aesthetic Medical International Holdings Group's earnings and revenue compare to its market cap? 3FMA fundamental statistics Market cap €15.82m Earnings (TTM ) -€6.37m Revenue (TTM ) €95.65m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 3FMA income statement (TTM ) Revenue CN¥726.67m Cost of Revenue CN¥396.84m Gross Profit CN¥329.82m Other Expenses CN¥378.24m Earnings -CN¥48.42m
Last Reported Earnings
Jun 30, 2024
Earnings per share (EPS) -1.01 Gross Margin 45.39% Net Profit Margin -6.66% Debt/Equity Ratio 1,285.9%
How did 3FMA perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/12 08:00 End of Day Share Price 2025/02/12 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Aesthetic Medical International Holdings Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Steven Halper Cantor Fitzgerald & Co.